,PIKfyvein vivo

Sophia M Min1, Frances M Bashore1, Jeffery L Smith1

  • 1Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

PubMed
概括

研究人员优化了化学探针的酸-3-酸5-激酶 (PIKfyve),产生强效的化合物,改善了体内稳定性. 化合物40显示出优异的选择性和口服生物可用性,使其成为进一步PIKfyve抑制研究的理想选择.